Historical salary details - Dr. Robert J. Wills, PhD, Chairman of the Board, Milestone Pharmaceuticals Inc
Dr. Robert J. Wills, PhD is the Chairman of the Board of Milestone Pharmaceuticals Inc.
Dr. Robert J. Wills, Phd
Chairman of the Board
-
Gross Remuneration
-
Current Company
Milestone Pharmaceuticals Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Milestone Pharmaceuticals Inc | Chairman of the Board | - | - |
| 2023 | Milestone Pharmaceuticals Inc | Chairman of the Board | 176.8 K | -17.9 % |
| 2023 | Oncternal Therapeutics Inc | Independent Director | 55.0 K | -19.4 % |
| 2023 | Cymabay Therapeutics Inc | Chairman of the Board | - | - |
| 2022 | Cymabay Therapeutics Inc | Chairman of the Board | 245.4 K | 3.2 % |
| 2022 | Milestone Pharmaceuticals Inc | Chairman of the Board | 215.2 K | 8.0 % |
| 2022 | Oncternal Therapeutics Inc | Director | 68.2 K | -50.8 % |
| 2021 | Cymabay Therapeutics Inc | Chairman of the Board | 237.8 K | -3.0 % |
| 2021 | Milestone Pharmaceuticals Inc | Chairman of the Board | 199.2 K | 20.2 % |
| 2021 | Oncternal Therapeutics Inc | Director | 138.6 K | 74.6 % |
| 2020 | Cymabay Therapeutics Inc | Chairman of the Board | 245.1 K | 8.5 % |
| 2020 | Milestone Pharmaceuticals Inc | Chairman of the Board | 165.8 K | - |
| 2020 | Oncternal Therapeutics Inc | Director | 79.4 K | -83.6 % |
| 2019 | Oncternal Therapeutics Inc | Director | 484.3 K | - |
| 2019 | Cymabay Therapeutics Inc | Chairman of the Board | 226.0 K | 23.1 % |
| 2018 | Cymabay Therapeutics Inc | Chairman of the Board | 183.5 K | -36.9 % |
| 2018 | Oncternal Therapeutics Inc | Executive Chairman of the Board | - | - |
| 2017 | Cymabay Therapeutics Inc | Chairman of the Board | 291.0 K | 280.6 % |
| 2017 | Oncternal Therapeutics Inc | Executive Chairman of the Board | - | - |
| 2016 | Cymabay Therapeutics Inc | Executive Chairman of the Board | 76.5 K | -46.5 % |
| 2016 | Oncternal Therapeutics Inc | Executive Chairman of the Board | - | - |
| 2015 | Cymabay Therapeutics Inc | Chairman of the Board | 142.8 K | - |
| 2015 | Oncternal Therapeutics Inc | Executive Chairman of the Board | - | - |
| 2014 | Cymabay Therapeutics Inc | Independent Director | - | - |
| 2014 | Oncternal Therapeutics Inc | Executive Chairman of the Board | - | - |